InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | Aikawa Yoshiyuki | Director & Chairman and CEO | Sale | 465.0K | $3.02 | $1.41M | 78.84M | View ↗ | |
| 2026-04-21 | Aikawa Yoshiyuki | Director & Chairman and CEO | Sale | 3.10M | $3.02 | $9.37M | 79.30M | View ↗ | |
| 2026-03-06 | Aikawa Yoshiyuki | Director & Chairman and CEO | Sale | 4.42M | $2.12 | $9.38M | 861.6K | View ↗ |
| Metric | FY2023 | FY2022 |
|---|---|---|
| Operating and formation costs | $1.6M+328.1% | $382K |
| Franchise tax expense | $137K-15.0% | $162K |
| Loss from Operations | -$1.8M-226.1% | -$544K |
| Interest and dividend income on investments held in Trust Account | $2.6M+96.4% | $1.3M |
| Income before income taxes | $869K+8.4% | $801K |
| Income tax expense | -$529K-112.8% | -$249K |
| Net income | $340K-38.5% | $553K |
| Common Class A [Member] | ||
| Basic weighted average shares outstanding, Class B common stock | $1.0M-62.4% | $2.7M |
| Basic net income per share, Class B common stock | $0.04-33.3% | $0.06 |
| Diluted weighted average shares outstanding, Class B common stock | $1.0M-62.4% | $2.7M |
| Diluted net income per share, Class B common stock | $0.04-33.3% | $0.06 |
| Common Class B [Member] | ||
| Basic weighted average shares outstanding, Class B common stock | $1.0M-62.4% | $2.7M |
| Basic net income per share, Class B common stock | $0.04-33.3% | $0.06 |
| Diluted weighted average shares outstanding, Class B common stock | $1.0M-62.4% | $2.7M |
| Diluted net income per share, Class B common stock | $0.04-33.3% | $0.06 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations
Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock
SBC: View Secondary Offering as a Positive For Share Trading Liquidity
SBC Medical announces pricing of 3.1M share secondary offering by selling stockholder
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
SBC Medical (SBC): A Miss on Paper — But There’s More Behind It
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update
SBC: Average Revenue / Customer Visit Trending Up; Expected Benefits of Expansion in Wellness & Longevity Areas
SBC Medical Group GAAP EPS of $0.14 beats by $0.03, revenue of $39.57M misses by $5.87M
SBC Medical Group announces $20 million share repurchase program
SBC Medical: Statistical Cheapness Masks Fundamental Flaws